Public Company News
Innovent and AnHeart Jointly Present Updated Phase 2 Efficacy and Safety Data of Taletrectinib (ROS1-TKI) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
* In 67 ROS1 TKI-naïve patients, the confirmed objective response rate (cORR) and disease control rate (DCR) were 92.5% and 95.5%, respectively. * In 38 crizotinib-pretreated patients, the cORR and DCR were 50% and 78.9%, respectively. * In 12 patients with brain metastasis and measurable...
2022-06-07 08:00
4054
USI Assists Customers in Launching Cloud Gateway to Make Cloud Services Both Efficient and Intelligent
SHANGHAI, June 7, 2022 /PRNewswire/ -- Cloud Gateway allows data to shift freely between different "protocols" and helps the calculation and data transfer. Recently, USI has collaborated with customers in developing a cloud gateway that can send messages from fire alarm systems to public clouds a...
2022-06-07 07:00
5419
/C O R R E C T I O N -- Altair/
In the news release, Altair Expands Design Technology for Additive Manufacturing with Acquisition of Gamma, issued06-Jun-2022 by Altair over PR Newswire, we are advised by the company that the headline should read "Altair Expands Design Technology for Additive Manufacturing with Acquisition of Ge...
2022-06-07 06:14
5508
Telix Showcasing Innovation in Theranostics at SNMMI
MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its presence at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting to be held inVancouver from June 11-14. Gallium-based pr...
2022-06-07 05:00
3100
Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Subgroup analysis of patients with no prior chemotherapy in EMERALD: A phase 3 trial evaluating elacestrant, an investigational oral selective estrogen receptor degrader (SERD), vs. investigator's choice of endocrine monotherapy for ER+/HER2- advanced/metastatic breast cancer (mBC) FLORENCE, Ita...
2022-06-06 23:07
4259
Cisco Unveils Innovations Driving New Security Cloud Strategy
News Summary: * Cisco unveiled its new strategic vision of a unified platform for end-to-end security across hybrid multi-cloud environments * The company is designing the Cisco Security Cloud to be the most open security platform with no public cloud lock-in * Cisco is taking steps to real...
2022-06-06 23:00
3617
Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker "PRE"
LONDON and HONG KONG, June 6, 2022 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the first quarter endedMarch 31, 2022. The Company recorded strong opera...
2022-06-06 21:55
6445
Cyient to Acquire Portugal-Based Celfinet to Strengthen its Wireless Communications Offerings
HYDERABAD, India, June 6, 2022 /PRNewswire/ -- Cyient, a leading consulting-led, industry-centric, global Technology Solutions company, today announced that it had signed definitive agreements to acquire Celfinet. An international Wireless Engineering Services company, Celfinet, is focused on pr...
2022-06-06 20:00
2933
Cuisine Solutions, Global Leader and Pioneer in Sous Vide Premium Foods, Announces $250 Million Growth Investment from Bain Capital
Investment to Accelerate Company's Growth and Global Expansion and Drive Further Culinary Innovation STERLING, Va. and BOSTON, Mass., June 6, 2022 /PRNewswire/ -- Cuisine Solutions Inc., the global leader and pioneer in sous vide premium foods, today announced a$250 million investment from Bain ...
2022-06-06 20:00
7400
Futu Holdings Achieves Solid First-Quarter Growth Amid Market Volatility with 67.9% YoY Increase in Paying Clients
- Flagship trading apps moomoo and Futubull have acquired 18.1 million global users as of quarter end PALO ALTO, Calif., June 6, 2022 /PRNewswire/ -- Moomoo's parent company Futu Holdings Limited (Nasdaq: FUTU) (Futu), a leading tech-driven online brokerage and wealth management platform, r...
2022-06-06 17:59
5467
Vection Technologies Announces Metaverse Integration for Webex Meetings at Cisco LIVE 2022
News Summary: * Vection Technologies is bringing its virtual worlds creation capabilities to Webex Meetings * Webex-first solution will be previewed at Cisco Live! in Las Vegas June 12-16 LAS VEGAS, June 6, 2022 /PRNewswire/ -- Vection Technologies is collaborating with Webex by Cisco to mak...
2022-06-06 14:18
3104
Gaotu Techedu Announces First Quarter of 2022 Unaudited Financial Results
BEIJING, June 6, 2022 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2022. First Quart...
2022-06-06 14:00
5062
Market update: Strong tanker market due to sanctions and high demand for oil - Concordia Maritime
GÖTEBORG, Sweden, June 6, 2022 /PRNewswire/ -- The product tanker market has strengthened significantly during April and May, with market rates at much higher levels than for both Q1 2022 and the full year 2021. At the end of May, average spot market earnings for an MR vessel (clean) was about$36...
2022-06-06 13:39
2989
CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer
* The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy * Sugemalimab became the first anti-PD-...
2022-06-06 13:15
4285
Poster Highlighting Phase II Clinical Study of KN026 for HER2-expressing Advanced GC/GEJ Presented at 2022 ASCO
SUZHOU, China, June 6, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK) jointly announced that data from a phase II clinical study of KN026 (HER2 bispecific antibody) monotherapy in patients with previously treated, advance...
2022-06-06 10:49
3418
Research Updates on KN046 Presented at 2022 ASCO
SUZHOU, China, June 6, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that research updates from four clinical studies of KN046 (PD-L1/CTLA-4 bispecific antibody) presented as a poster or published online at the 2022 American Society of Clinical Oncology Annual Meeting (20...
2022-06-06 09:47
3636
SocietyOne launches transaction & savings accounts powered by Westpac
SYDNEY, June 6, 2022 /PRNewswire/ -- In its first major corporate milestone
following its acquisition by MONEYME Ltd (ASX:MME), digital finance platform
SocietyOne has launched transaction and savings accounts powered by Westpac's
Banking-as-a-Service (BaaS).
2022-06-06 09:25
4095
WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes
* WuXi Biologics offers global partners high-efficiency and high-quality manufacturing services for clinical trial and commercial supply by increasing pre-filled syringes (PFS) capacity to 17 million units per year. * WuXi Biologics has established a global manufacturing network with 9 drug p...
2022-06-06 08:30
4905
Innovent Presents Clinical Data of IBI110 (Anti-LAG-3 Monoclonal Antibody) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...
2022-06-06 08:08
3941
Innovent Presents Clinical Data of Phase I Study for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Solid Tumors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
SAN FRANCISCO and SUZHOU, China, June 6, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and ...
2022-06-06 08:00
4017
Week's Top Stories
Most Reposted
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
[Picked up by 327 media titles]
2026-08-05 11:34
MetaOptics Sharpens Focus on Metalens Commercialisation; Withdraws Nasdaq Listing Application, and Defers U.S. Dual Listing Plan
[Picked up by 311 media titles]
2026-08-07 22:30Thailand Ready to Welcome 191 Countries to the 2026 Annual Meetings of the International Monetary Fund and the World Bank Group
[Picked up by 299 media titles]
2026-08-06 15:10
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
[Picked up by 298 media titles]
2026-08-04 07:00
Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
[Picked up by 294 media titles]
2026-08-04 14:30
Most Read
Hyatt Regency Kuala Lumpur At KL Midtown: A Refined Urban Retreat Recognised For Design Excellence
2026-08-04 07:00
13678
Mastercard elevates premium travel with Asia Pacific's first Taste by Priceless dining club at Hong Kong International Airport
2026-08-05 11:34
11818
Gene Solutions Advances Precision Oncology Education in Malaysia with the ''Beyond Actionable'' Academy
2026-08-04 06:00
10155
Vitafoods Asia Announces Strategic Move to Kuala Lumpur for 2027 Edition
2026-08-04 14:30
9813